SCTC-21-C
N/A
Report date: 2026/04/21 20:00:18
Base Information
Drug NameSCTC-21-C
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[7]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesSinoCelltech Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesSinoCelltech Ltd
Inactive CompaniesN/A
Active Indications +[7]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A